...
首页> 外文期刊>Radiation oncology >Resistance training concomitant to radiotherapy of spinal bone metastases – survival and prognostic factors of a randomized trial
【24h】

Resistance training concomitant to radiotherapy of spinal bone metastases – survival and prognostic factors of a randomized trial

机译:抗性训练伴随着脊髓骨转移的放射治疗 - 随机试验的存活率和预后因素

获取原文

摘要

Purpose To compare the effects of resistance training versus passive physical therapy on bone survival in the metastatic bone during radiation therapy (RT) as combined treatment in patients with spinal bone metastases. Secondly, to evaluate overall survival and progression-free-survival (PFS) as well as to quantify prognostic factors of bone survival after combined treatment. Methods In this randomized trial 60 patients were allocated from September 2011 until March 2013 into one of the two groups: resistance training (group A) or passive physical therapy (group B) with thirty patients in each group during RT. We estimated patient survival using Kaplan-Meier survival method. The Wald-test was used to evaluate the prognostic importance of pathological fracture, primary site, Karnofsky performance status, localization of metastases, number of metastases, and cerebral metastases. Results Median follow-up was 10?months (range 2–35). Bone survival showed no significant difference between groups ( p = .303). Additionally no difference between groups could be detected in overall survival ( p = .688) and PFS ( p = .295). Local bone progression was detected in 16.7?% in group B, no irradiated bone in group A showed a local progression over the course ( p = 0.019). In univariate analysis breast cancer, prostate cancer, and the presence of cerebral metastases had a significant impact on bone survival in group B, while no impact could be demonstrated in group A. Conclusions In this group of patients with spinal bone metastases we were able to show that guided resistance training of the paravertebral muscles had no essential impact on survival concomitant to RT. Importantly, no local bone progression in group A was detected, nevertheless no prognostic factor for combined treatment could be evaluated. Trial registration Clinical trial identifier NCT 01409720 . Registered 8 February 2011.
机译:目的,用于比较抗被动物理治疗对脊髓骨转移患者的转移性骨中骨存取的抗被动物理治疗对转移性骨骼的影响。其次,评估整体存活和无进展生存(PFS),并在组合治疗后量化骨存期的预后因素。该随机试验中的方法60例患者于2011年9月分配到2013年3月,进入两组中的一组:在室温下,每组中有三十名患者的阻力训练(A组)或被动物理治疗(B组)。我们使用Kaplan-Meier生存方法估计患者存活。沃尔德检验用于评估病理骨折,原源部位,Karnofsky性能状况,转移局部,转移次数和脑转移的预后重要性。结果中位后续行动为10?月(范围2-35)。骨存活表明,组之间没有显着差异(p = .303)。另外,在总存活中没有分组之间的差异(P = .688)和PFS(P = .295)。在B组的16.7℃下检测到局部骨进展,A组中没有辐照骨显示在过程中的局部进展(P = 0.019)。在单变量分析乳腺癌中,前列腺癌和脑转移的存在对B组骨存活产生了重大影响,而A组可以证明该组患者的结论我们能够患有我们能够的脊髓骨转移患者表明,椎旁肌的引导阻力训练对存活的根本影响伴随到室温。重要的是,检测到A组中的局部骨进展,然而可以评估组合治疗的预后因素。试验登记临床试验标识符NCT 01409720。注册2011年2月8日。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号